Abstract:Understanding early Alzheimer's disease (AD) pathogenesis holds the hope for prevention and early treatment of the disease. We have recently reported that sub-threshold soluble β-amyloid (Aβ) in vitro decreases membrane (functional) levels of G-protein coupled receptor kinase-5 (GRK5), and that such membrane GRK5 deficiency occurs prior to cognitive decline and persists to late stages in an AD transgenic model. Moreover, similar changes were also observed in postmortem human AD brain samples. These results support a possible novel link between GRK5 deficiency and early AD. To determine whether the GRK5 deficiency is pathogenic or compensatory. If it is pathogenic, to what extent does it contribute to AD pathogenesis? GRK5 knockout (GRK5KO) mouse is a model resembling GRK5 deficiency, but without genetic modifications of any previously known AD pathogenic or risk factors (i.e., β-amyloid precursor protein, presenilins, tau, apolipoprotein E, etc.). To determine potential roles of GRK5 in the disease pathogenesis, the GRK5KO mouse was evaluated at pathological and behavioral levels with focuses on AD-like changes. We found that these mice displayed an age-dependent increase of hippocampal axonal defects characterized by clusters of axonal swellings that accumulated abnormal amounts of molecular motor proteins, microtubule-associated proteins, intracellular β-amyloid, and subcellular organelles. Similar changes were also evidenced in piriform cortex, amygdaloid and anterior olfactory nuclei. In severe cases, extracellular β-amyloid fibrillar deposits were occasionally observed in hippocampus, along with degenerating axonal components, and were tightly surrounded by reactive astrocytes. Moreover, significant loss of synaptic proteins and early signs of cholinoceptive neurodegeneration were demonstrated in hippocampus as well. Furthermore, these pathologic changes were significantly worse in the female mice than the male. Consistent with the moderate level of pathologic change, aged GRK5KO mice displayed selective working memory impairment, with other cognitive domains unaffected. Our findings not only strongly support an important role of GRK5 deficiency in early Alzheimer's pathogenesis, but also promote the GRK5KO mouse as a novel model for early Alzheimer-related studies.

Emx1-Cre-mediated Inactivation of PDK1 Prevents Plaque Deposition in an Alzheimer’s Disease-Like Mouse Model

Genetic Inhibition of PDK1 Robustly Reduces Plaque Deposition and Ameliorates Gliosis in the 5×FAD Mouse Model of Alzheimer's Disease

A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer's disease

Programmed Cell Death Protein 1 Blockade Reduces Glycogen Synthase Kinase 3β Activity and Tau Hyperphosphorylation in Alzheimer’s Disease Mouse Models

Inhibition of PKCδ reduces amyloid-β levels and reverses Alzheimer disease phenotypes

Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer's disease

Early Disruption of Synaptic Function, Impairment of Plasticity, and Decreased of Cortical Circuit Connectivity in an Alzheimer’S Mouse Model of Amyloid Deposition

Modeling sporadic Alzheimer's disease in mice by combining Apolipoprotein E4 risk gene with environmental risk factors

A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease

Synaptic deficits are rescued in the p25/Cdk5 model of neurodegeneration by the reduction of β-secretase (BACE1)

Genetic Ablation of Hematopoietic Cell Kinase Accelerates Alzheimer’s Disease–Like Neuropathology in Tg2576 Mice

P‐133: GRK5 Deficient Mouse is a Novel Model for Early Alzheimer's Disease

PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer's Disease

Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model

A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease

Parkin Overexpression Ameliorates Hippocampal Long-Term Potentiation and -Amyloid Load in an Alzheimer's Disease Mouse Model

Modulating Adult Neurogenesis Affects Synaptic Plasticity and Cognitive Functions in Mouse Models of Alzheimer's Disease.

Reversible GABAergic dysfunction involved in hippocampal hyperactivity predicts early-stage Alzheimer disease in a mouse model

Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.

Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer's disease

Early impairment of cortical circuit plasticity and connectivity in the 5XFAD Alzheimer’s disease mouse model